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The four-step total synthesis of ()-chaetominine†
Qi-Long Peng,‡ Shi-Peng Luo,‡ Xiao-Er Xia, Liang-Xian Liu and Pei-Qiang Huang*
The total synthesis of the alkaloid ()-chaetominine (1) has been
achieved in four steps with an overall yield of 33.4%. Key features of
our strategy include a one-pot cascade indole epoxidation – epoxide
ring-opening cyclization – lactamization reaction sequence, and the
use of a nitro group as a latent amino group for the one-pot construc-
tion of the quinazolinone ring. This constitutes a step economical,
redox economical and protecting group-free total synthesis.
Efficiency is a major pursuit in organic synthesis, which is of
particular importance in the field of the total synthesis of complex
natural products.1 With this end in view, the concepts of step
economy,2 pot economy,3 redox economy,4 and protecting group-
free synthesis5 have been introduced. Recently, a number of quite
concise total syntheses have been achieved.6
In 2006, Tan and co-workers reported the isolation of a new
alkaloid ()-chaetominine (1 in Fig. 1) from the solid-substrate
culture of Chaetomium sp. IFB-E015, an endophytic fungus on
apparently healthy Adenophora axilliflora leaves.7 The intriguing
structural feature in combination with the reported potent
activity against human leukemia K562 (21 nM) and colon cancer
SW1116 (28 nM) cell lines7 made ()-chaetominine an attractive
synthetic target.8 Snider and co-workers reported the first total
synthesis of ()-chaetominine soon after its isolation.8a Later
on, Evano and Papeo reported the second8b and the third
approaches.8c Papeo’s work also clarified that ()-chaetominine
(1) showed a negligible inhibitory activity on several cancer
cell lines.8c The fourth one disclosed by Evano et al. has so far
been the most efficient with nine steps and 14% overall yield
from D-tryptophan.8d
With our interest in the asymmetric synthesis of bioactive
natural products9 and the development of step economical synthetic
methodologies,10 we envisaged that ()-chaetominine (1) is an
ideal molecule for demonstrating the concepts of step economy,
pot economy, redox economy, and protecting group-free synthesis.
We report herein a four-step total synthesis of ()-chaetominine (1)
starting from D-tryptophan.11
Our retrosynthetic analysis of ()-chaetominine (1) is depicted
in Scheme 1. The key feature of our approach resides in the
ambitious one-pot formation of ()-chaetominine (1) from
Fig. 1 Structure of ()-chaetominine (1).
Scheme 1 Retrosynthetic analysis of ()-chaetominine (1).
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quinazolinonetripeptide 2 via a one-pot cascade indole
epoxidation – epoxide ring-opening cyclization – lactamization
reaction sequence. The formation of the pyrrolo[2,3-b]indole
ring system through b-oxygenation of tryptophan derivatives
followed by nucleophilic addition at the a-position has been
known for a long time, which includes the photosensitized
oxygenation,12 and Witkop’s stepwise oxidative transposition.13
Recently, much attention has been paid to the oxidative cyclization
of tryptophan derivatives,14–16 due to the presence of the pyrrolo-
[2,3-b]indole ring system in many bioactive alkaloids.17 Nevertheless,
to the best of our knowledge, no redox and protecting group-free
oxidative cyclization leading to the fused six-membered ring system
(piperidino[2,3-b]indole) has ever been reported.12–17 Even in the
cases where formation of both five or six-membered rings was
possible, the five-membered ring product (pyrrolo[2,3-b]indole)
always dominated over the six-membered ring.14b,d In the first
total synthesis of kapakahines B and F,14b,c Baran and co-workers
have developed an elegant method for the access to the
tetrahydro-1H-pyrido[2,3-b]indole ring system of kapakahines
by in situ kinetic trapping of a dynamic mixture.
Thus construction of the tricyclic core of ()-chaetominine
(1) from the tryptophan derived dipeptide 2 via epoxidative
cyclization appeared to be quite challenging. Nevertheless,
considering the high efficiency of this approach, it was worth-
while to be engaged in this adventure.
As regards the quinazolinone ring system, a number of methods
have been reported.18 In view of developing a protecting group-free
total synthesis of ()-chaetominine (1), the nitro group was envisioned
as a latent amino group for the construction of the quinazolinone
ring. Thus o-nitrobenzoyl dipeptide derivative 3 was envisaged as
the intermediate of our synthesis, which is readily accessible from
commercially available D-tryptophan, o-nitrobenzoyl chloride, and
L-alanine methyl ester hydrochloride salt.
Our synthesis started with the aroylation of D-tryptophan
with o-nitrobenzoyl chloride (THF, 1 M NaOH, 0 1C, 2 h), which
gave the aroylated product 4 in 90% yield (Scheme 2). Successive
treatment of compound 4 with i-BuOCOCl/N-methylmorpholine
(NMM, THF, 20 1C, 15 min) and the L-alanine methyl ester
hydrochloride salt (THF, NMM, 20 1C, 8 h) produced the desired
dipeptide derivative 3 in 91% yield. The quinazolinone ring system18
was constructed by a modification of Shi’s method.19 In the event, 3
was treated with HC(OMe)3 and low valent titanium generated in situ
from TiCl4 and Zn powders in THF at 0–5 1C, which gave the desired
quinazolinone 2 in 97% yield without observable epimerization.
Higher temperature reported by Shi and co-workers19 led to
substantial epimerization.
With compound 2 in hand, we then focused on the key
epoxidation-initiated cascade reaction to construct the tricyclic
core of ()-chaetominine (1). Although treatment of dipeptide 2
with a solution of DMDO in acetone at 78 1C for up to 1 h led
to complex products, the results implied that the epoxidation might
have occurred, but the unstable epoxide intermediate failed to
cyclize to give the desired product 1. So, basic conditions were
envisaged to be necessary to realize the cascade epoxidation-bis-
cyclization reactions (Scheme 2). In view of the easy epimerization of
our substrate (vide supra), weak basic conditions are preferred to
avoid any epimerization during the cyclization. After considerable
experimentation, it was found that a combination of DMDO with
DMSO gave optimal results. In the event, dipeptide 2 was first
treated with DMDO in acetone at 78 1C for 1 h, and then DMSO
(CaH2 dried) was added, and the mixture was stirred at rt for 2 days
to give the desired chaetominine (1) in 42% yield, along with a small
portion of its lactamization precursor 5 (3% yield) and an epimer of
the latter (6) in 51% yield. The structure of ()-chaetominine (1) was
confirmed by single crystal X-ray analysis.20 The physical {[a]20D 49.7
(c 0.48, MeOH) lit. 48 (c 0.45, MeOH);8a 49.4 (c 0.26, MeOH);8b,c
47.9 (c 0.25, MeOH);8d 70 (c 0.48, MeOH)7} and spectral data of
our synthetic ()-chaetominine (1) are identical to those reported.
The structure of compound 6 was tentatively deduced from its
cyclized product 7 and the bromo derivative 8, both determined
Scheme 2 Reagents and conditions: (i) o-nitrobenzoyl chloride, 1 M NaOH, THF, 0 1C, 2 h; (ii) H-L-Ala-OMeHCl, ClCO2iBu, NMM, THF, 20 1C, 8 h; (iii)
HC(OMe)3, Zn/TiCl4, THF, 0 1C, 1 day; (iv) DMDO, acetone, 78 1C, 1 h; then, DMSO (CaH2 dried), rt, 48 h. Syntheses of compounds 7 and 8 for single
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by single crystal X-ray analysis.20 The direct formation of
chaetominine (1) from 2 implied that an anti–cis disposition
between the hydroxyl group at C3 and the quinazolinonyl group
favors the lactamization. For diastereomer 6, the fact that only
in the presence of a base can the lactamization occur implied a
syn-disposition between the substituents at C3 and C14.
It is worth mentioning that although the yield of chaetomi-
nine (1) from 2 via the epoxidation-trigged cascade reaction was
modest, the strategy is highly efficient. In this cascade reaction
sequence, three reactions have been accomplished in one-pot,
which also avoided the use of any protecting group. In the
previous syntheses,8a–d the highest diastereoselectivity (95% de)
has been achieved with DMDO in Evano’s first generation total
synthesis of ()-chaetominine (1).8b However, five steps were
required to build the tricyclic ring system, which let them to
abandon that route and develop a more efficient one.8d
In summary, we have disclosed a very concise and efficient
strategy for the total synthesis of ()-chaetominine (1) starting
from D-Trp. This four-step total synthesis of ()-chaetominine
(1) has so far been the shortest one, with the highest overall
yield of 33.4%.
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